Quell Opioid Reduction and Pain Relief in Patients With Cancer

Stopped early · Not applicable · Has a placebo group

Conditions studied: Pain, Metastatic Breast Cancer, Prostate Cancer, Colorectal Cancer

In brief

To study effects the Quell device has on opioid consumption and pain relief in patients with cancer.

Key facts

Study ID

NCT02809846

Run by

Scripps Translational Science Institute

People needed

33

Starts

2016-07-01

Expected to finish

2017-10-01

Last updated by the study team

2020-01-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or Female greater than or equal to 18 year of age at visit one.
• Documented diagnosis of metastatic breast, prostate or colorectal cancer with a prognosis of 6 month or greater as determined by the primary oncologist.
• Visual evidence that subject owns a smart phone and is able to use basic mobile applications such as downloading an app, opening the app, and performing one simple task within the app.
• Subject speaks and reads English fluently.
• Subject able to understand and grant informed consent.
• Live in an area with cellular data connectivity available as provided by the subject.
• Documented adherence with clinic follow up visits per medical records.
• Subject using at least one opioid medication on a daily basis.

You may not qualify if…

• Subject has a cardiac pacemaker, implanted defibrillator or other implanted electronic device.
• Inability to complete subjective data as required; e.g. on mobile application and questionnaires.
• Does not live in an area with suitable cellular data connectivity.
• Has infrequent scheduled clinic visits.

Where it is running

• Scripps Translational Science Institute — La Jolla, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.